Wednesday, 24 July 2019

Folic Acid Decreases Dolutegravir-Linked Neural Tube Defects Risk

Dolutegravir medication for treating HIV infection has been linked to a 6- to 9-fold increase in the risk for neural tube defects among babies born to mothers receiving the drug during early gestation.


from Medindia Health News https://ift.tt/30QSlYB

No comments:

Post a Comment